Banner - NPPA Connect

News


All News

Fine scaly papules

A 62-year-old man with a history of hypothyroidism presented with a rash of fine scaly papules that had coalesced into a confluent orange-red plaque covering a large area of his trunk. He told the doctor it had started on his scalp about two weeks earlier and spread from there. Now the skin of his palms and soles had thickened and developed an orange hue.

There are many ways to accomplish creative fashionable nail appearances. learn what's trending and what you need to know about nail polish to educate your patients.

To prevent filler-related complications, Dr. Cohen and his staff focus on understanding the anatomy of the skin and what lies beneath the areas that they’re injecting. Learn to practice safe principles for prepping the skin.

The very lasers that dermatologists have in their practices to treat wrinkles, acne scars and pigmented lesions have the power to rehabilitate the most disfiguring of burns and other scars. Learn more

Zika considerations

How should the typical dermatologist fit consideration of Zika into the day-to-day operations of his or her practice? Dr. Ted Rosen separates fact from fallacy.

Design your office space with optimization in mind to improve workflow, patient and staff satisfaction, and physician efficiency.

Find your work-life balance

Recommendations to get you thinking about how you can improve your work/life balance and guard against burnout. How to gain control.

Read and follow along as Dr. Elaine Siegfried shares her insight into obsessive diagnosing disorder, and how it can be a blessing and a curse.

Novartis announced January 15 that the FDA has approved secukinumab (Cosentyx, Novartis) for psoriatic arthritis (PsA) and active ankylosing spondylitis. The announcement comes a year after the FDA’s approval for secukinumab for treatment of adults with moderate to severe psoriasis. The drug is the only IL-17A antagonist approved for all three indications. learn more

Dr. Hensin Tsao, shares his insight on why skin cancer cases are increasing, how new immunotherapy treatments bring hope and why dermatologists should be on the look out for new challenges.

Is your Facebook, Twitter or other social sites working for your practice? Not sure or maybe you need a little help. Check out what experts have to say about launching a successful media campaign for your practice. Get the tips.

Here’s an opportunity: Go to a foreign country and teach dermatologists about modern surgical techniques. Here’s the catch: It’s on your dime. Learn why derms should become global mentors and it's benefits.

Promius Pharma, the U.S. subsidiary of Hyderabad, India-based Dr. Reddy’s Laboratories, announced FDA news on two of the company’s dermatology drugs. learn more

The age at which a patient first develops indications of psoriatic arthritis may influence various disease factors. Early onset appears to be associated with more extensive disease; while late onset is associated with several metabolic complications. Here’s what this means.

A 67-year-old man visited his dermatologist complaining of a rash that had developed over the past two weeks that caused intense pruritus. The small scaly papules were in a follicular configuration on his back. His wife told him the rash had developed a few blisters. He noticed it was worse after his daily workout when he worked up a sweat.

As research advances understanding of psoriasis, drug development evolves to address various pathways to disease. A number of possibilities, now in clinical trials, appear safe, effective and promising with improved long-term clearance rates.